Cognitive impairment in multiple sclerosis

被引:1597
作者
Chiaravalloti, Nancy D. [1 ,2 ]
DeLuca, John [1 ,2 ,3 ]
机构
[1] Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA
[2] Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, Dept Neurol & Neurosci, Newark, NJ 07103 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1474-4422(08)70259-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is a progressive disease of the CNS that is characterised by widespread lesions in the brain and spinal cord. MS results in motor, cognitive, and neuropsychiatric symptoms, all of which can occur independently of one another. The common cognitive symptoms include deficits in complex attention, efficiency of information processing, executive functioning, processing speed, and long-term memory. These deficits detrimentally affect many aspects of daily life, such as the ability to run a household, participate fully in society, and maintain employment-factors that can all affect the overall quality of life of the patient. The increased use of neuroimaging techniques in patients with MS has advanced our understanding of structural and functional changes in the brain that are characteristic of this disease, although much remains to be learned. Moreover, examination of efforts to treat the cognitive deficits in MS is still in the early stages.
引用
收藏
页码:1139 / 1151
页数:13
相关论文
共 213 条
[81]  
FISCHER JS, 2001, HDB MULTIPLE SCLEROS, P233
[82]  
FISCHER JS, 1988, CLIN NEUROPSYCHOL, V2, P149, DOI DOI 10.1080/13854048808520097
[83]   PSYCHOIMMUNOLOGICAL DYSREGULATION IN MULTIPLE-SCLEROSIS [J].
FOLEY, FW ;
MILLER, AH ;
TRAUGOTT, U ;
LAROCCA, NG ;
SCHEINBERG, LC ;
BEDELL, JR ;
LENNOX, SS .
PSYCHOSOMATICS, 1988, 29 (04) :398-403
[84]  
Foley FW, 1994, J NEUROLOGIC REHABIL, V8, P165, DOI [DOI 10.1177/136140969400800401, 10.1177/136140969400800401]
[85]   Executive function in multiple sclerosis - The role of frontal lobe pathology [J].
Foong, J ;
Rozewicz, L ;
Quaghebeur, G ;
Davie, CA ;
Kartsounis, LD ;
Thompson, AJ ;
Miller, DH ;
Ron, MA .
BRAIN, 1997, 120 :15-26
[86]   CORRELATION OF NEUROPSYCHOLOGICAL AND MRI FINDINGS IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
FRANKLIN, GM ;
HEATON, RK ;
NELSON, LM ;
FILLEY, CM ;
SEIBERT, C .
NEUROLOGY, 1988, 38 (12) :1826-1829
[87]   Immunomodulatory agents for the treatment of relapsing multiple sclerosis [J].
Galetta, SL ;
Markowitz, C ;
Lee, AG .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2161-2169
[88]  
Gaudino EA, 2001, NEUROPSY NEUROPSY BE, V14, P32
[89]   The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis [J].
Geisler, MW ;
Sliwinski, M ;
Coyle, PK ;
Masur, DM ;
Doscher, C ;
Krupp, LB .
ARCHIVES OF NEUROLOGY, 1996, 53 (02) :185-188
[90]   DEPRESSION, COGNITIVE IMPAIRMENT AND SOCIAL STRESS IN MULTIPLE-SCLEROSIS [J].
GILCHRIST, AC ;
CREED, FH .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1994, 38 (03) :193-201